Presenter:
Geoffrey Smelski, PharmD, DABAT
Clinical Education Director
Arizona Poison and Drug Information Center
Description: Join us in our Envenomations series for another perspective on our slithery desert dwelling neighbors ... venomous snakes! On behalf of the Arizona Poison and Drug Information Center, Dr. Smelski will be discussing the different strategies for treating venomous snakebites throughout history.
Learning Objectives:
Describe the historical development of rattlesnake antivenom and explain how evolving regulatory oversight has influenced current clinical standards for its use.
Assess the strength and limitations of available evidence supporting treatment strategies in order to inform management decisions.
Implement evidence-based management strategies for rattlesnake envenomation and avoid outdated or harmful interventions associated with a low likelihood of benefit.
Continuing Medical Education
Accreditation Statement: The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Relevant Financial Relationships Statement(s): University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.
